Curing Heart Attacks, Replacing Diseased Organs—Christopher Chen Is Engineering a Healthier Future

Christopher Chen was a teenager when he first started thinking seriously about what makes the human body such an amazing machine. An avid runner and soccer player, Chen injured his knee, sidelining him from sports for a while. His knee eventually got better on its own, but during this time of convalescence, Chen mused about replacement surgery—even the best materials, developed with the most cutting-edge technology, would eventually break down. If he had needed a knee replacement, he’d need another surgery at some point, and maybe even another after that.

Tagged: ,

Converging on Training Tomorrow’s Bioengineers

With an NSF grant, a BU program will train a diverse group of PhD students for tomorrow’s workforce in biotech, synthetic biology, and other sectors.

Tagged: , , , , , , , , , , , , ,

Biotech Developing “Tissue Therapeutics” to Treat Diseased Organs Launches from BU and MIT Labs

Greater Boston has become the nation’s biotech hub—the Silicon Valley of life sciences, according to some—and Massachusetts is now reportedly home to more than 1,000 biotech companies, employing more than 80,000 people. One of the newest multimillion-dollar firms helping to drive the boom has its roots in a Boston University lab. Satellite Bio—fueled by technology codeveloped by BU biomedical engineer Christopher Chen—launched in April after announcing it had secured $110 million in venture funding.

Tagged:

Newly Named Allen Distinguished Investigators Aim to Recreate Lungs

The Paul G. Allen Family Foundation has awarded funding to a trio of BU faculty for a bold, early-stage project aimed at lab-grown lungs that mimic the real organ in all its fractal complexity. The proposal of Associate Professor Wilson Wong (BME), Professor Christopher Chen (BME, MSE), and School of Medicine Professor Darrell Kotton has […]

Tagged: , ,